Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 4/2020

01-10-2020 | Thalassemia | Images

Pseudo-Thrombocytosis Caused by Extreme Microcytosis in a Patient with Alpha Thalassemia Trait

Authors: Alexander A. Slota, Devin Malik, Diane Hall

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 4/2020

Login to get access

Excerpt

While automated blood counts have revolutionized laboratory medicine and hematology, there are instances in which visualization of a peripheral blood smear is superior to instrument values. We describe a 57-year-old African American male with alpha thalassemia trait with spurious thrombocytosis. While thrombocytopenia can be a complication of hypersplenism in thalassemia [1], thrombocytosis is rare in alpha thalassemia trait [2]. Our patient’s baseline platelet count was 250 × 109/L. However, laboratory results noted transiently elevated platelet counts routinely between 1200 × 109/L and 2000 × 109/L. He also had anemia (hemoglobin 85 g/L) and microcytosis (MCV 56.9 fl). …
Literature
1.
go back to reference Vichinsky E (2010) Complexity of alpha thalassemia: growing health problem with new approaches to screening, diagnosis, and therapy. Ann N Y Acad Sci 1202:180–187CrossRef Vichinsky E (2010) Complexity of alpha thalassemia: growing health problem with new approaches to screening, diagnosis, and therapy. Ann N Y Acad Sci 1202:180–187CrossRef
2.
go back to reference Taylor S, Strauch S, Lewis S (2015) Thrombocytosis in a patient with alpha thalassemia trait. Lab Med 46:e7–e12CrossRef Taylor S, Strauch S, Lewis S (2015) Thrombocytosis in a patient with alpha thalassemia trait. Lab Med 46:e7–e12CrossRef
Metadata
Title
Pseudo-Thrombocytosis Caused by Extreme Microcytosis in a Patient with Alpha Thalassemia Trait
Authors
Alexander A. Slota
Devin Malik
Diane Hall
Publication date
01-10-2020
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 4/2020
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-020-01297-6

Other articles of this Issue 4/2020

Indian Journal of Hematology and Blood Transfusion 4/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine